{
    "clinical_study": {
        "@rank": "43495", 
        "arm_group": {
            "arm_group_label": "Device implantation", 
            "arm_group_type": "Experimental", 
            "description": "Implantation of device"
        }, 
        "brief_summary": {
            "textblock": "Current treatment options for bilateral profoundly deaf children, diagnosed with inner ear\n      anatomical abnormalities are limited, and in the case of absent cochleas, non-existent.  An\n      auditory brainstem implant (ABI) places an electrode close to the auditory nucleus in the\n      brainstem.  Children aged 2 - 5 who are not candidates for a cochlear implant, or who did\n      not demonstrate benefit from a cochlear implant, will be implanted with an ABI and followed\n      for 1 year for safety and a total of 3 years for preliminary efficacy.  This is a\n      feasibility study to determine the safety of the ABI."
        }, 
        "brief_title": "Feasibility Study of Auditory Brainstem Implant in Young Children", 
        "completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Bilateral Cochlear Aplasia", 
            "Bilateral Cochlear Nerve Deficiency", 
            "Bilateral Cochlear Ossification Secondary to Meningitis"
        ], 
        "condition_browse": {
            "mesh_term": "Meningitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Bilateral profound deafness due to cochlear aplasia, cochlear nerve deficiency, or\n             ossification secondary to meningitis\n\n          -  If previously received a cochlear implant, must demonstrate lack of benefit from that\n             device\n\n        Exclusion Criteria:\n\n          -  Medical contraindication to craniotomy/intracranial surgery\n\n          -  Severe cognitive or developmental delays"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01850225", 
            "org_study_id": "Ped ABI"
        }, 
        "intervention": {
            "arm_group_label": "Device implantation", 
            "intervention_name": "Auditory brainstem implant", 
            "intervention_type": "Device", 
            "other_name": "Cochlear Corporation Nucleus 24"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 10, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90057"
                }, 
                "name": "House Research Institute CARE Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Feasibility Study of the Placement, Use, and Safety of the Nucleus 24 Auditory Brainstem Implant in Non-Neurofibromatosis Type 2 (NF2) Pediatric Patients", 
        "overall_official": [
            {
                "affiliation": "House Research Institute", 
                "last_name": "Eric Wilkinson, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "House Research Institute", 
                "last_name": "Laurie Eisenberg, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Count of the number of expected serious adverse events must not exceed that known to occur in pediatric retrosigmoid craniotomy and Count of the number of unexpected serious adverse events must not exceed 2 in the first 5 children.", 
            "measure": "Number of Serious Adverse Events", 
            "safety_issue": "Yes", 
            "time_frame": "12-month post-activation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01850225"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "ability to detect sounds", 
            "measure": "Access to sound at a level (dB) and within the frequency range (500-4000 Hz), known to be associated with speech", 
            "safety_issue": "No", 
            "time_frame": "3 years post-activation"
        }, 
        "source": "House Research Institute", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "House Clinic", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Children's Hospital Los Angeles", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "House Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}